ImpriMed is a Silicon Valley located healthcare startup developing AI-based cancer precision diagnosis and treatment technology. ImpriMed focuses on pet cancer analysis and provides fast diagnosis and treatment system through pharmaceutical reaction. In the pet industry, a half of them is gone due to the cancer, a quarter of them struggles with tumors, and 12 million dogs and cats are diagnosed with cancer. ImpriMed plans to expand their business and markets(South Korea and Japan) on its personalized precision diagnosis and treatment technology applied to pet cancer, which has proved its cost saving and time efficiency benefit.